• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在闭塞性动脉疾病动物模型中,克罗卡林(BRL 34915)及其他增强膜钾离子电导的化合物可增强肌肉血细胞通量和氧分压,但钙拮抗剂或肼苯哒嗪则无此作用。

Enhancement of muscle blood cell flux and pO2 by cromakalim (BRL 34915) and other compounds enhancing membrane K+ conductance, but not by Ca2+ antagonists or hydralazine, in an animal model of occlusive arterial disease.

作者信息

Angerbach D, Nicholson C D

机构信息

Beecham-Wülfing Research Laboratories, Gronau, Federal Republic of Germany.

出版信息

Naunyn Schmiedebergs Arch Pharmacol. 1988 Mar;337(3):341-6. doi: 10.1007/BF00168848.

DOI:10.1007/BF00168848
PMID:3393236
Abstract

The effect of Ca2+ antagonists, hydralazine and agents which enhance membrane K+ conductance (cromakalim, pinacidil and nicorandil) in smooth muscle cells, was compared on normal and hypoxic skeletal muscle blood cell flux and pO2. The K+ conductance enhancers and verapamil, diltiazem and nifedipine increased blood cell flux in normally perfused muscle. At equieffective blood pressure lowering dosages, the Ca2+ antagonists produced greater increases than the K+ channel openers. Hydralazine did not elevate blood cell flux in the normal muscle. In hypoxic skeletal muscle, the K+ conductance enhancers produced a marked increase in blood cell flux and in tissue oxygen tension, indicating that they had increased the nutritive blood flow in the muscle. The Ca2+ antagonists and hydralazine either did not change hypoxic muscle blood cell flux and pO2 or reduced them. The dissimilarity in the activity of the compounds may be due to differences in their site of action in the vascular bed. Ca2+ antagonists and hydralazine are known to reduce arteriolar vessel resistance and do not increase blood flow in hypoxic skeletal muscle. The positive effect of cromakalim, pinacidil and nicorandil may be due to relaxant activity on larger arterial blood vessels including collaterals. This effect could be related to their ability to enhance membrane K+ conductance in vascular smooth muscle cells.

摘要

比较了钙离子拮抗剂、肼屈嗪以及增强细胞膜钾离子电导的药物(克罗卡林、匹那地尔和尼可地尔)对正常和缺氧骨骼肌血细胞流量及氧分压的影响。钾离子电导增强剂以及维拉帕米、地尔硫䓬和硝苯地平可增加正常灌注肌肉中的血细胞流量。在等效降压剂量下,钙离子拮抗剂比钾离子通道开放剂能使血细胞流量增加得更多。肼屈嗪不会提高正常肌肉中的血细胞流量。在缺氧骨骼肌中,钾离子电导增强剂可使血细胞流量和组织氧张力显著增加,这表明它们增加了肌肉中的营养性血流。钙离子拮抗剂和肼屈嗪要么不会改变缺氧肌肉的血细胞流量和氧分压,要么会使其降低。这些化合物活性的差异可能归因于它们在血管床中作用部位的不同。已知钙离子拮抗剂和肼屈嗪可降低小动脉血管阻力,且不会增加缺氧骨骼肌中的血流量。克罗卡林、匹那地尔和尼可地尔的积极作用可能归因于它们对包括侧支血管在内的较大动脉血管的舒张活性。这种作用可能与其增强血管平滑肌细胞膜钾离子电导的能力有关。

相似文献

1
Enhancement of muscle blood cell flux and pO2 by cromakalim (BRL 34915) and other compounds enhancing membrane K+ conductance, but not by Ca2+ antagonists or hydralazine, in an animal model of occlusive arterial disease.在闭塞性动脉疾病动物模型中,克罗卡林(BRL 34915)及其他增强膜钾离子电导的化合物可增强肌肉血细胞通量和氧分压,但钙拮抗剂或肼苯哒嗪则无此作用。
Naunyn Schmiedebergs Arch Pharmacol. 1988 Mar;337(3):341-6. doi: 10.1007/BF00168848.
2
Cytoplasmic calcium and the relaxation of canine coronary arterial smooth muscle produced by cromakalim, pinacidil and nicorandil.细胞质钙与克罗卡林、匹那地尔和尼可地尔引起的犬冠状动脉平滑肌舒张
Br J Pharmacol. 1990 Sep;101(1):157-65. doi: 10.1111/j.1476-5381.1990.tb12106.x.
3
Potassium channel modulation: a new drug principle for regulation of smooth muscle contractility. Studies on isolated airways and arteries.钾通道调节:一种调节平滑肌收缩性的新药理原则。对离体气道和动脉的研究。
Dan Med Bull. 1996 Dec;43(5):429-47.
4
The resistance of some rat cerebral arteries to the vasorelaxant effect of cromakalim and other K+ channel openers.一些大鼠脑动脉对克罗卡林和其他钾通道开放剂血管舒张作用的抗性。
Br J Pharmacol. 1992 Jan;105(1):51-8. doi: 10.1111/j.1476-5381.1992.tb14209.x.
5
The negative inotropic effect of nicorandil is independent of cyclic GMP changes: a comparison with pinacidil and cromakalim in canine atrial muscle.尼可地尔的负性肌力作用与环磷酸鸟苷变化无关:与匹莫齐特和克罗卡林在犬心房肌中的比较。
Br J Pharmacol. 1988 Oct;95(2):393-8. doi: 10.1111/j.1476-5381.1988.tb11658.x.
6
Cromakalim, a potassium channel activator: a comparison of its cardiovascular haemodynamic profile and tissue specificity with those of pinacidil and nicorandil.克罗卡林,一种钾通道激活剂:其心血管血流动力学特征及组织特异性与匹那地尔和尼可地尔的比较
J Cardiovasc Pharmacol. 1988;12(5):535-42.
7
Cromakalim does not protect against skeletal muscle fatigue in an anaesthetized rat model of acute hindlimb ischaemia.在急性后肢缺血的麻醉大鼠模型中,克罗卡林不能预防骨骼肌疲劳。
Eur J Pharmacol. 1993 Nov 30;250(1):109-16. doi: 10.1016/0014-2999(93)90627-t.
8
Evidence that pinacidil may promote the opening of ATP-sensitive K+ channels yet inhibit the opening of Ca2(+)-activated K+ channels in K(+)-contracted canine mesenteric artery.有证据表明,吡那地尔可能促进ATP敏感性钾通道开放,但抑制钾离子收缩的犬肠系膜动脉中钙激活钾通道的开放。
Br J Pharmacol. 1990 May;100(1):143-9. doi: 10.1111/j.1476-5381.1990.tb12066.x.
9
Modulation of intracellular calcium by potassium channel openers in vascular muscle.钾通道开放剂对血管平滑肌细胞内钙的调节作用
Naunyn Schmiedebergs Arch Pharmacol. 1991 Dec;344(6):706-15. doi: 10.1007/BF00174755.
10
Specificity of action of the novel antihypertensive agent, BRL 34915, as a potassium channel activator. Comparison with nicorandil.新型抗高血压药物BRL 34915作为钾通道激活剂的作用特异性。与尼可地尔的比较。
Biochem Pharmacol. 1987 Nov 1;36(21):3663-9. doi: 10.1016/0006-2952(87)90017-7.

引用本文的文献

1
K(ATP) channel therapeutics at the bedside.床边的钾离子通道开放剂治疗学
J Mol Cell Cardiol. 2005 Jul;39(1):99-112. doi: 10.1016/j.yjmcc.2005.04.006.
2
Modulation of vasodilatation to levcromakalim by hypoxia and EDRF in the rabbit isolated ear: a comparison with pinacidil, sodium nitroprusside and verapamil.缺氧和内皮舒张因子对兔离体耳中左旋克罗卡林血管舒张作用的调节:与吡那地尔、硝普钠和维拉帕米的比较。
Br J Pharmacol. 1993 Jun;109(2):386-93. doi: 10.1111/j.1476-5381.1993.tb13581.x.
3
Therapeutic potential of potassium channel openers in peripheral vascular disease and asthma.

本文引用的文献

1
Haemodynamic studies on experimental obstruction of the femoral artery in the cat with special reference to the peripheral action of vasoactive substances.
Acta Physiol Scand Suppl. 1962;57(199):1-95. doi: 10.1111/j.1748-1716.1962.tb02621.x.
2
Regional blood flow and cardiac responses to hydralazine.肼屈嗪对局部血流及心脏的反应。
J Pharmacol Exp Ther. 1980 Feb;212(2):294-303.
3
Muscle blood flow disturbances produced by simultaneously elevated venous and total muscle tissue pressure.
Microvasc Res. 1980 Nov;20(3):307-18. doi: 10.1016/0026-2862(80)90031-x.
4
钾通道开放剂在周围血管疾病和哮喘中的治疗潜力。
Cardiovasc Drugs Ther. 1993 Aug;7 Suppl 3:555-63. doi: 10.1007/BF00877621.
4
Modulation of vasodilatation to levcromakalim by adenosine analogues in the rabbit ear: an explanation for hypoxic augmentation.腺苷类似物对兔耳中左旋克罗卡林血管舒张的调节作用:对缺氧增强作用的一种解释。
Br J Pharmacol. 1994 May;112(1):49-54. doi: 10.1111/j.1476-5381.1994.tb13027.x.
5
Smooth muscle K+ channel openers; their pharmacology and clinical potential.平滑肌钾通道开放剂;其药理学及临床应用潜力
Pflugers Arch. 1989;414 Suppl 1:S99-105. doi: 10.1007/BF00582256.
6
The protective effects of cromakalim and pinacidil on reperfusion function and infarct size in isolated perfused rat hearts and anesthetized dogs.克罗卡林和吡那地尔对离体灌注大鼠心脏及麻醉犬再灌注功能和梗死面积的保护作用。
Cardiovasc Drugs Ther. 1990 Apr;4(2):465-74. doi: 10.1007/BF01857755.
7
Potassium channel openers. Pharmacological effects and future uses.钾通道开放剂。药理作用及未来用途。
Drugs. 1990 Dec;40(6):785-91. doi: 10.2165/00003495-199040060-00002.
8
Spasmolytic effect of cromakalim in dog coronary artery in vitro.克罗卡林对犬冠状动脉的体外解痉作用。
Naunyn Schmiedebergs Arch Pharmacol. 1991 May;343(5):519-24. doi: 10.1007/BF00169555.
9
The resistance of some rat cerebral arteries to the vasorelaxant effect of cromakalim and other K+ channel openers.一些大鼠脑动脉对克罗卡林和其他钾通道开放剂血管舒张作用的抗性。
Br J Pharmacol. 1992 Jan;105(1):51-8. doi: 10.1111/j.1476-5381.1992.tb14209.x.
10
Effects of BRL 38227, sodium nitroprusside and verapamil on collateral perfusion following acute arterial occlusion in the rabbit isolated ear.BRL 38227、硝普钠和维拉帕米对兔离体耳急性动脉闭塞后侧支循环灌注的影响。
Br J Pharmacol. 1992 Jun;106(2):315-23. doi: 10.1111/j.1476-5381.1992.tb14334.x.
Calcium antagonist and the peripheral circulation: differences and similarities between PY 108-068, nicardipine, verapamil and diltiazem.钙拮抗剂与外周循环:PY 108 - 068、尼卡地平、维拉帕米和地尔硫䓬之间的异同
Br J Pharmacol. 1983 Feb;78(2):375-94. doi: 10.1111/j.1476-5381.1983.tb09403.x.
5
The acute effects of nifedipine on calf and forefoot blood flow in patients with peripheral arterial insufficiency.硝苯地平对周围动脉供血不足患者小腿和前足血流的急性影响。
Angiology. 1983 Jan;34(1):46-52. doi: 10.1177/000331978303400106.
6
The hypotensive mechanisms of the new anti-anginal drug, N-(2-hydroxyethyl)nicotinamide nitrate (SG-75) in beagle dogs.新型抗心绞痛药物N-(2-羟乙基)烟酰胺硝酸盐(SG-75)在比格犬体内的降压机制
Jpn J Pharmacol. 1981 Dec;31(6):921-9. doi: 10.1254/jjp.31.921.
7
A new instrument for continuous measurement of tissue blood flow by light beating spectroscopy.一种通过光拍频光谱法连续测量组织血流的新型仪器。
IEEE Trans Biomed Eng. 1980 Jan;27(1):12-9. doi: 10.1109/TBME.1980.326686.
8
Vascular effects in dogs of pinacidil (P 1134), a novel vasoactive antihypertensive agent.
Eur J Pharmacol. 1983 Apr 8;88(4):389-92. doi: 10.1016/0014-2999(83)90591-5.
9
Vasodilators: minoxidil and drugs used in peripheral vascular and cerebral disorders.血管扩张剂:米诺地尔以及用于外周血管和脑部疾病的药物。
Br Med J (Clin Res Ed). 1983 Apr 16;286(6373):1262-4. doi: 10.1136/bmj.286.6373.1262.
10
Calcium antagonists. Mechanisms, therapeutic indications and reservations: a review.钙拮抗剂。作用机制、治疗适应症及注意事项:综述
Q J Med. 1984 Winter;53(209):1-16.